A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC)
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: TQB2450|DRUG: Anlotinib|DRUG: Paclitaxel for Injection (albumin bound)
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.